Home › GSK melanoma drug combination wins accelerated U.S. approval
 

Keywords :   


GSK melanoma drug combination wins accelerated U.S. approval

2014-01-09 20:14:48| Biotech - Topix.net

A combination treatment from GlaxoSmithKline for melanoma, the deadliest form of skin cancer, has won accelerated approval from U.S. regulators.

Tags: combination drug approval wins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11contactglove tundratracker
23.11
23.11RUSSELUNO
23.11C282 800yd IP54
23.11X-FLY4 27.5
23.118
23.11 (1~40)
23.1101DVDBOX
More »